PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Title only   |   Print    Next page > 
     
Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin® in the Asia-Pacific Market
Everest Medicines has obtained exclusive rights for the clinical development and commercialization of Bejescin ® (MIL62, Obinutuzumab beta Injection) across the Asia-Pacific region, including Southeast ...
2026-06-04T    Health Care/Hospital   Medical/Pharmaceuticals 
Waterdrop Inc. to Report First Quarter 2026 Financial Results on June 16, 2026
BEIJING , June 4, 2026 /PRNewswire/ -- Waterdrop Inc. (NYSE:  WDH ) ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare service ...
2026-06-04T    Banking/Financial Service   Computer/Electronics   Health Care/Hospital 
World's First CLDN18.2 ADC for Regulatory Review: Innovent Biologics Announces IBI343 (arcotatug tavatecan) Met Primary Endpoint in International Phase 3 Study in Advanced Refractory Gastric Cancer and NDA Accepted by China NMPA
SAN FRANCISCO and SUZHOU, China , June 4, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes ...
2026-06-04T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Lupeng Pharmaceutical's Fourth-Generation BTK Inhibitor Rocbrutinib Approved in China for Relapsed or Refractory Mantle Cell Lymphoma
GUANGZHOU, China , June 4, 2026 /PRNewswire/ -- Lupeng Pharmaceutical today announced that the National Medical Products Administration (NMPA) has granted accelerated approval to rocbrutinib (development ...
2026-06-04T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
111, Inc. Announces First Quarter 2026 Unaudited Financial Results
Continuing Transition toward a More Asset-Light and Operationally Efficient Business Model Net Revenue of Promotional Products (1) Increased by 70.2% and Gross Profit Rose by 75.0% Year-over-Year ...
2026-06-04T    Health Care/Hospital   Medical/Pharmaceuticals   Retail 
TelkomMetra Strengthens Its Business Portfolio Restructuring Strategy, AdMedika Group Ready for Distinct Expansion under Fullerton Health
This strategic initiative aligns with Danantara Indonesia's streamlining directive to TelkomGroup in strengthening its structure and sharpening its business focus. ...
2026-06-04T    Banking/Financial Service   Health Care/Hospital   Telecommunications 
2026 World Cup: Global Health Leaders Demand FIFA End its Coca-Cola Partnership - Vital Strategies
NEW YORK , June 4, 2026 /PRNewswire/ -- A formidable coalition of global health experts and advocates is demanding FIFA commit to ending its partnership with Coca-Cola by 2030. The Kick Big Soda ...
2026-06-04T    Entertainment   Health Care/Hospital   Retail 
MEDIPOST Secures FDA Agreement on Single Pivotal Phase 3 Study with Confirmatory Evidence BLA Filing Strategy for CARTISTEM® in the U.S.
SEOUL, South Korea , June 4, 2026 /PRNewswire/ -- MEDIPOST, a fully integrated commercial stage cell therapy biotechnology company, announced today that it has secured the FDA's agreement to conduct ...
2026-06-04T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Quantinuum Announces Pricing of Upsized Initial Public Offering
BROOMFIELD, Colo. , June 4, 2026 /PRNewswire/ -- Quantinuum Inc. ("Quantinuum") today announced the pricing of the upsized initial public offering of 28,000,000 shares of its Class A common ...
2026-06-04T    Banking/Financial Service   Computer/Electronics   Health Care/Hospital 
ERA Congress: Semaglutide linked to better quality of life in diabetes and kidney disease, FLOW trial shows
GLASGOW, Scotland , June 4, 2026 /PRNewswire/ -- New   findings from the landmark FLOW trial, presented at the 63 rd ERA Congress, show that once-weekly semaglutide significantly improved health-related ...
2026-06-04T    Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2026
Suntek Computer Systems Limited.
All rights reserved